Judith Klimovsky, MD, has been appointed executive vice president and chief development officer (CDO), Genmab. Dr. Klimovsky will lead the company’s global product development activities and will join the executive team. Dr. Klimovsky will be responsible for Genmab’s product development strategy in line with the company’s corporate strategy. Dr. Klimovsky brings extensive drug development experience, most recently serving as senior vice president and global head, Oncology Clinical Development...